| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/14/2001 | EP1076066A1 Peptides for lowering blood glucose levels |
| 02/14/2001 | EP1075514A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 02/14/2001 | EP1075272A1 Methods for treating diabetes by inhibiting gdf-8 |
| 02/14/2001 | CN1284066A Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 02/14/2001 | CN1283622A 6-hydroxy-3(4-[2-(piperidine-1-group)oxyethyl group]phenoxy)-2-(4-methoxy phenyl) benzo[b] thiophene hydrochloride salt |
| 02/14/2001 | CN1283497A Oral liquid for treating cerebrovascular disease and its preparing process |
| 02/14/2001 | CN1061844C External-use antithyroid cream |
| 02/13/2001 | US6187788 Thieno(2,3-b)(dihydro)pyridine derivatives; gonadotropin-releasing hormone antagonists; anticarcinogenic agents; sexual and urogenital disorders |
| 02/13/2001 | US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
| 02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
| 02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
| 02/08/2001 | WO2001009182A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 02/08/2001 | WO2001009116A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009115A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/08/2001 | WO2001008673A1 Calcilytic compounds |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2000067785A3 Staphyloccocus aureus antigen-containing whole cell vaccine |
| 02/08/2001 | WO2000066590A3 Tetracyclic progesterone receptor modulator compounds and methods |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | CA2380081A1 Calcilytic compounds |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/07/2001 | EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |
| 02/07/2001 | EP1074558A1 Process for the preparation of mometasone furoate |
| 02/07/2001 | EP1073454A1 Methods for treating hot flashes and gynaecomastia |
| 02/07/2001 | CN1283200A Androfenic Steroid compounds and method of making and using the same |
| 02/07/2001 | CN1283118A Pharmaceutical grade ginseng |
| 02/07/2001 | CN1282744A Preparation of furoic acid momisone |
| 02/06/2001 | US6184249 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | CA2155872C Oxytocin antagonist |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007462A1 11β-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007417A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 02/01/2001 | WO2001007036A1 BICYCLIC ANTAGONISTS SELECTIVE FOR THE αvβ3 INTEGRIN |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378860A1 Bicyclic antagonists selective for the .alpha.v.beta.3 integrin |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1071753A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/31/2001 | EP1071447A1 Treatment for diabetes |
| 01/31/2001 | EP1071428A2 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 01/31/2001 | EP1071423A1 Antagonists of gonadotropin releasing hormone |
| 01/31/2001 | EP1071407A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 01/31/2001 | CN1282250A Progestin therapy with controlled bleeding |
| 01/30/2001 | US6180803 Steroid drugs |
| 01/30/2001 | US6180642 Sexual disorders; contraceptives |
| 01/29/2001 | CA2314682A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/28/2001 | CA2314572A1 Estrogen agonists and antagonists for multiple indications |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005820A2 Method for down-regulating gdf-8 activity |
| 01/25/2001 | WO2001005806A1 Orally active androgens |
| 01/25/2001 | WO2001005791A2 NEW PROCESS FOR THE PREPARATION OF N-(1,1-DIMETHYLETHYL)-4-[[5'-ETHOXY-4-cis-[2-(4-MORFOLINO)ETHOXY]-2'-OXOSPIRO[CYCLOHEXAN-1,3'-[H]INDOL]-1'(2'H)-yl]-SULFONYL]-3-METHOXYBENZAMIDE AND ITS SALTS |
| 01/25/2001 | WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005380A1 Sustained release compositions, process for producing the same and use thereof |
| 01/25/2001 | WO2000059946A8 Hydroxymatairesinol in cancer prevention |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000058360A3 Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
| 01/25/2001 | WO2000056297A3 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth |
| 01/25/2001 | DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists |
| 01/25/2001 | CA2379852A1 Method for down-regulating gdf-8 activity |
| 01/25/2001 | CA2379545A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | CA2379223A1 Orally active androgens |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378714A1 Sustained release compositions, methods for producing the same and uses thereof |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070707A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1070064A1 Antagonists of gonadotropin releasing hormone |
| 01/24/2001 | EP1070059A1 Chromanone and thiochromanone derivatives |
| 01/24/2001 | EP0694039B1 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity |
| 01/24/2001 | CN1281466A Aggregates of human insulin derivatives |
| 01/24/2001 | CN1281429A Novel aryloxy-alkyl-dialkylamines |
| 01/24/2001 | CN1281361A Use of aromatase inhibitor in treatment of uropoiesis disease and method for studying uropoiesis disease |
| 01/24/2001 | CN1280857A Medicinal composition for treating thyroidism |